Alterity Therapeutics presents at the American Academy of Neurology Annual Meeting May 3, 2019August 16, 2022
Alterity announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson’s disease clinical trials February 9, 2021August 16, 2022